How to take and dose fezolinetant
Fezolinetant is a new non-hormonal drug used to relieve hot flashes and related symptoms in menopausal women. Its dosage regimen emphasizes precision and safety. Before starting treatment, patients need to undergo a baseline liver function assessment, including blood biochemistry testing, to determine liver function status and potential risk of injury. During treatment, it is recommended to conduct follow-up blood tests at the 3rd, 6th and 9th month after the start of treatment to detect liver function abnormalities in time and adjust the dose or suspend treatment if necessary. In addition, if clinical symptoms suggestive of liver damage occur, such as jaundice, loss of appetite, or fatigue, blood tests should be obtained immediately.

The standard recommended dose is 45mg each time taken orally once a day. Fezonatant can be taken with or without food, and drug absorption and bioavailability are not significantly affected. In order to keep the blood drug concentration stable, you should try to take the drug at a fixed time every day, and avoid adjusting the dose yourself or missing medication. If you miss a dose, take it as soon as you remember, but if it is less than 12 hours before the next dose, skip the dose and continue as originally planned.
There is currently a lack of official guidance on capsule disintegration or suspension for patients with dysphagia, so alternatives should be sought under the guidance of a physician or other routes of administration should be considered. Patients should pay attention to physical reactions during use, including improvements in hot flashes, changes in sleep quality, and any adverse reactions such as nausea, fatigue, or abnormal liver function. Through standardized medication and follow-up examinations, the efficacy of fezonastat can be maximized while reducing potential safety risks.
In general, the method of taking filazonetant is simple and only needs to be taken once a day. At the same time, it needs to be accompanied by regular liver function monitoring to ensure safety. Its unique mechanism of action provides menopausal women with a non-hormonal treatment option that can effectively improve the quality of life.
Reference materials:https://www.veozah.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)